These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3056534)

  • 1. Ultrasonographic study of ovaries of 19 women with weight loss-related hypothalamic oligo-amenorrhea.
    Futterweit W; Yeh HC; Mechanick JI
    Biomed Pharmacother; 1988; 42(4):279-83. PubMed ID: 3056534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal cytology in endocrinopathies.
    Efstratiades M; Panitsa-Faflia C; Batrinos M
    Acta Cytol; 1983; 27(4):421-5. PubMed ID: 6576541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Histometric study of the ovaries in women with ovarian hyperandrogenism and syndromes related to damage to the corpus luteum].
    Chavrakov G; Georgiev Ch
    Akush Ginekol (Sofiia); 1979; 18(5):365-8. PubMed ID: 517701
    [No Abstract]   [Full Text] [Related]  

  • 5. Indications for and limitations of laparoscopic ovarian biopsy.
    Portuondo JA; Navarro E; Benito JA; Obregon MJ
    J Reprod Med; 1982 Feb; 27(2):67-72. PubMed ID: 6212674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body composition of oligo/amenorrheic athletes.
    Carlberg KA; Buckman MT; Peake GT; Riedesel ML
    Med Sci Sports Exerc; 1983; 15(3):215-7. PubMed ID: 6621308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hysteroscopic evaluation and endocrinological aspects of women with müllerian anomalies and oligomenorrhea.
    Sørensen SS
    Int J Fertil; 1987; 32(6):445-52. PubMed ID: 2891632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroidogenic acute regulatory protein (StAR) in the ovaries of healthy women and those with polycystic ovary syndrome.
    Kahsar-Miller MD; Conway-Myers BA; Boots LR; Azziz R
    Am J Obstet Gynecol; 2001 Dec; 185(6):1381-7. PubMed ID: 11744913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of quality of life scores among non-exercising adolescent females and adolescent dancers with oligomenorrhea and amenorrhea.
    To WW; Wong MW
    J Pediatr Adolesc Gynecol; 2007 Apr; 20(2):83-8. PubMed ID: 17418391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminating hypothalamic oligomenorrhea/amenorrhea from hyperandrogenic oligomenorrhea/amenorrhea in exercising women.
    Koltun KJ; Williams NI; Scheid JL; De Souza MJ
    Appl Physiol Nutr Metab; 2020 Jul; 45(7):707-714. PubMed ID: 31815525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adolescent menstrual irregularity.
    Mansfield MJ; Emans SJ
    J Reprod Med; 1984 Jun; 29(6):399-410. PubMed ID: 6379175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian morphology in oligomenorrhea.
    Govan AD; Black WP
    Eur J Obstet Gynecol Reprod Biol; 1975; 5(6):317-25. PubMed ID: 1053525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka.
    Kumarapeli V; Seneviratne Rde A; Wijeyaratne CN; Yapa RM; Dodampahala SH
    Am J Epidemiol; 2008 Aug; 168(3):321-8. PubMed ID: 18550559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycystic ovarian disease.
    Gindoff PR; Jewelewicz R
    Obstet Gynecol Clin North Am; 1987 Dec; 14(4):931-53. PubMed ID: 3328131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Has oligomenorrhea a pathological meaning? The importance of this symptom in internal medicine].
    Devoto E; Aravena L; Gaete X
    Rev Med Chil; 1998 Aug; 126(8):943-51. PubMed ID: 9830746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian stromal hypertrophy in polycystic ovary syndrome.
    Kaleli S; Erel CT; Oral E; Elter K; Akman C; Colgar U
    J Reprod Med; 1998 Oct; 43(10):893-7. PubMed ID: 9800673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fasting urinary calcium/creatinine and hydroxyproline/creatinine values in young women with amenorrhoea and in matched eumenorrhoeic controls.
    Goulding A; Rae BG; Bland R
    N Z Med J; 1989 Dec; 102(881):629-30. PubMed ID: 2608225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovulatory disorders in women with polycystic ovary syndrome.
    Franks S; Adams J; Mason H; Polson D
    Clin Obstet Gynaecol; 1985 Sep; 12(3):605-32. PubMed ID: 3933879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of post-pill amenorrhea.
    Molitch ME; Reichlin S
    Drug Ther (NY); 1979 Sep; 9(9):93-102. PubMed ID: 12279395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycystic ovarian disease: US features in 104 patients.
    Yeh HC; Futterweit W; Thornton JC
    Radiology; 1987 Apr; 163(1):111-6. PubMed ID: 3547491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.